tiprankstipranks
Tourmaline Bio (TRML)
NASDAQ:TRML
US Market
Holding TRML?
Track your performance easily

Tourmaline Bio (TRML) Ownership - Who Owns Tourmaline Bio?

467 Followers

Tourmaline Bio (TRML) Ownership Overview

7.23%9.42%7.55%8.54%67.26%
7.55% Other Institutional Investors
8.54% ETFs
67.26% Public Companies and Individual Investors
The ownership structure of Tourmaline Bio (TRML) stock is a mix of institutional, retail, and individual investors. Approximately 25.51% of the company’s stock is owned by Institutional Investors, 7.23% is owned by Insiders, and 67.26% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 22, 2024
xxxxxxxxxxxxx
$26418
Aug 20, 2024
xxxxxxxxxxxxx
$71998
Jan 31, 2024
Mark Mcdade
Director
xxxxxxxxxxxxx
$3250000
Nov 20, 2023
xxxxxxxxxxxxx
$67960

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$2031198
Jun 30, 2024
xxxxxxxxxxxxx
$32650575

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,538,925Institution9.90%71,902,356
1,070,177Institution4.17%30,307,413
1,017,762Institution3.97%28,823,020
974,558Insider3.80%27,599,483
889,595Institution3.47%25,193,330
742,209Insider2.89%21,019,359
347,498Institution1.36%9,841,143
245,908Institution0.96%6,964,115
236,782Institution0.92%6,705,666
160,486Institution0.63%4,544,964

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
889,595Institution3.47%25,193,330
347,498Institution1.36%9,841,143
245,908Institution0.96%6,964,115
236,782Institution0.92%6,705,666
160,486Institution0.63%4,544,964
128,889Institution0.50%3,650,136
110,348Institution0.43%3,125,055
75,000Institution0.29%2,124,000
61,424Institution0.24%1,739,528
51,741Institution0.20%1,465,305

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
628,585Institution2.45%17,801,527
646,415Institution2.52%16,619,330
248,136Institution0.97%6,379,577
220,456Institution0.86%6,243,314
105,139Institution0.41%2,977,536
105,529Institution0.41%2,713,151
52,743Institution0.21%1,493,682
22,634Institution0.09%640,995
20,097Institution0.08%569,147
15,267Institution0.06%439,079

FAQ

Who Owns Tourmaline Bio (TRML)?
According to the latest TipRanks data, approximately 7.55% of the company's stock is held by institutional investors, 7.23% is held by insiders, and 67.26% is held by retail investors.
    What percentage of Tourmaline Bio (TRML) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 7.55% of Tourmaline Bio (TRML) stock is held by institutional investors.
      What percentage of Tourmaline Bio (TRML) stock is held by retail investors?
      According to the latest TipRanks data, approximately 67.26% of Tourmaline Bio (TRML) stock is held by retail investors.
        Who owns the most shares of Tourmaline Bio (TRML)?
        Peter Kolchinsky owns the most shares of Tourmaline Bio (TRML).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis